I-Xifaxan (i-Rifaximin) ye-IBS-D ne-Non Constipation IBS

I-Xifaxan (rifaximin) iyimithi elwa namagciwane e-FDA-evunyelwe ukwelashwa kwesifo sohudo- esiyinkimbinkimbi esishubileyo esiswini (IBS-D), kanye nesifo sohudo . I-Xifaxan nayo isetshenziselwe ukuphatha ukukhukhulwa kwamagciwane amancane emathumbu ( SIBO ).

I-Xifaxan isebenza kanjani?

I-Xifaxan ithathwa ngomlomo, kathathu ngosuku isikhathi seviki ezimbili. Uma ukuphazamiseka kwesifo okwanele kungafinyeleleki, imithi ingahle iphindwe ngokuphindaphindiwe ukuze kube nezifundo ezingu-14 ngaphezulu kwezinsuku ezingu-14.

I-Xifaxan ayitholakali esiswini ngakho-ke kucatshangwa ukuba yenze amabhaktheriya atholakala emathunjini amancane namakhulu. Ikhwalithi engenayo ukumisa ye-Xifaxan imiphumela emiphumeleni encane emzimbeni wonke.

Okuqhamuka uma udla imishanguzo

I-Xifaxan ivame ukubekezelela kahle. Ezilingo zomtholampilo, imiphumela embi emibi ivame ukuhambisana nalabo be- placebo . Imiphumela emibi yemiphumela ibekiwe:

• Ukuqokwa
• Isizungu
• Izinwele
• I-nausea kanye / noma ukuhlanza

Uma kwenzeka uhlangabezana nanoma yimiphi imiphumela emibi elandelayo lapho uthatha i-Xifaxan, kufanele uxhumane nodokotela wakho ngokushesha:

• Izimpawu zokwelapha, ezifana nobunzima bokuphefumula; imifuba, ukucheka noma ukuqhuma; noma ukuvuvukala kwezindebe, ubuso noma ulimi
• Fever
• Uhudo olusemanzini noma olunegazi

I-FDA incoma ukuthi uma imithi idlula izimpawu zakho zokuhuda, kufanele uhlolwe ngesifo socansi C ..

I-Xifaxan akufanele isetshenziswe uma unenkinga enkulu yesibindi.

Ingabe i-Xifaxan iphumelele ye-IBS?

Ukuhlolwa kwemitholampilo kuze kube yimanje kuboniswe ukuthi i-Xifaxan iphumelela kakhulu kune-placebo ekunciphiseni izimpawu zesisu esiswini kanye nokuthuthukiswa kwesimo sezinyawo.

Ukucwaninga kuze kube yimanje kuye kwabonisa ukuthi i-Xifaxan ibekezelelwe kahle futhi ibonakala iphephile ukusetshenziswa kwesikhathi esifushane. Abanye abantu bangadinga izifundo ezingaphezu kweyodwa zomuthi ukuze bafinyelele imiphumela efunayo.

_Imithombo:

_{"I-FDA ivumela ukwelashwa okubili ukuphatha isaziso se-IBS-D" FDA Press ngoMeyi 27, 2015.}

_{I-Ford, A., etal. "I- American College of Gastroenterology Monograph ekuphathweni kwe-Irritable Bowel Syndrome ne-Chronic Idiopathic Constipation " I- American Journal of Gastroenterology 2014 109: S2-S26.}

_{UGaman, A., Bucur, M. & Kuo, B. Ukuthuthukiswa kwezinsizakalo ezenzweni zesisu zomzimba: isifo sofuba esiswini. Intuthuko yokwelashwa ku-Gastroenterology, 2009 2: 169-181.}